Source:http://linkedlifedata.com/resource/pubmed/id/11709421
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-11-15
|
pubmed:abstractText |
Transgenic mice overexpressing beta-tropomyosin have increased myofilament Ca(2+) sensitivity that we hypothesized would result in altered relationships among pressure and heart rates, intracellular Ca(2+), and myocardial O(2) consumption. In perfused hearts from transgenic mice there was a marked negative force-frequency response between 6 and 10 Hz with a 30 +/- 3% reduction in peak-positive first derivative of pressure development over time (dP/dt) compared with 14 +/- 2% in wild-type mice (P < 0.001). At 8 Hz systolic pressures were normal, though peak systolic intracellular Ca(2+) was significantly reduced in transgenic mice versus wild type (726 +/- 61 vs. 936 +/- 67 nM, P < 0.05) indicating an alteration in the pressure-Ca(2+) relationship. Over a wide range of positive and negative inotropic interventions there were normal developed pressures, though marked elevations in myocardial O(2) consumption (15-54%). Because pressures are normal and intracellular Ca(2+) decreased and myocardial O(2) consumption increased, this suggests that these abnormalities are at least in part compensatory mechanisms to the altered myofilament function.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0363-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
281
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H2539-48
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11709421-Animals,
pubmed-meshheading:11709421-Blood Pressure,
pubmed-meshheading:11709421-Calcium,
pubmed-meshheading:11709421-Calcium Signaling,
pubmed-meshheading:11709421-Cardiotonic Agents,
pubmed-meshheading:11709421-Dobutamine,
pubmed-meshheading:11709421-Male,
pubmed-meshheading:11709421-Mice,
pubmed-meshheading:11709421-Mice, Transgenic,
pubmed-meshheading:11709421-Myocardial Contraction,
pubmed-meshheading:11709421-Myocardium,
pubmed-meshheading:11709421-Oxygen Consumption,
pubmed-meshheading:11709421-Perfusion,
pubmed-meshheading:11709421-Tropomyosin
|
pubmed:year |
2001
|
pubmed:articleTitle |
Compensatory changes in Ca(2+) and myocardial O(2) consumption in beta-tropomyosin transgenic hearts.
|
pubmed:affiliation |
Cardiovascular Institute of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. macgowanga@msx.upmc.edu
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|